Back to Agenda
Module 1: Overview of Drug Development
Session Chair(s)
Stephen V. O'Quinn, PharmD
President
Perissos, Inc., United States
- Objectives Derived From Desired Label
- Regulatory Oversight/ and Requirements
- Workstreams and Interrelationships
- Timeline
- Risk and Resources
- Summary
Have an account?